non glp 1 weight loss drugs π¨ GLP-1 DRUGS: A BREAKTHROUGH OR A NEW RISK? π€π, π₯ βThe Hidden Side of GLP-1s: Could Weight Loss Trigger Eating Disorders?β π₯, GLP-1 medications such as semaglutide and tirzepatide Compound versions of GLP-1 drugs
Description
Compliance with Ethical Standards Human and Animal Rights and Informed Consent This article does not contain any studies with human or animal subjects performed by any of the authors

Sanyal, P

355:2297-2307 [PubMed: 17135584] 109

Insurance Coverage Trulicity: Often on diabetes medication formularies May be preferred due to established relationships with Eli Lilly Prior authorization typically required Ozempic: Also commonly covered for diabetes May face step therapy requirements Prior authorization typically required Coverage varies by plan: Some plans prefer one medication over the other based on rebate agreements

Lipodystrophy in insulin-treated subjects and other injection-site skin reactions: Are we sure everything is clear

GLP-1RAs improve hyperglycemia by enhancing insulin secretion through increases in -cell cytoplasmic cyclic adenosine monophosphate [53], which activates protein kinase A (PKA) and, thus, increases in intracellular calcium and triggers insulin exocytosis in a glucose-dependent manner [54]
